376 related articles for article (PubMed ID: 23282186)
1. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
[TBL] [Abstract][Full Text] [Related]
2. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
J Virol; 2017 May; 91(10):. PubMed ID: 28250124
[TBL] [Abstract][Full Text] [Related]
3. Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein.
Wang Q; Wang S; Shi Z; Li Z; Zhao Y; Feng N; Wang T; Yan F; Xia X
Front Cell Infect Microbiol; 2024; 14():1341332. PubMed ID: 38746783
[TBL] [Abstract][Full Text] [Related]
4. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
[TBL] [Abstract][Full Text] [Related]
6. Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.
Emmerich P; Mika A; von Possel R; Rackow A; Liu Y; Schmitz H; Günther S; Sherifi K; Halili B; Jakupi X; Berisha L; Ahmeti S; Deschermeier C
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006366. PubMed ID: 29579040
[TBL] [Abstract][Full Text] [Related]
7. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
[TBL] [Abstract][Full Text] [Related]
8. A novel double-antigen sandwich ELISA for the species-independent detection of Crimean-Congo hemorrhagic fever virus-specific antibodies.
Sas MA; Comtet L; Donnet F; Mertens M; Vatansever Z; Tordo N; Pourquier P; Groschup MH
Antiviral Res; 2018 Mar; 151():24-26. PubMed ID: 29330092
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside-Modified mRNA Vaccines Protect IFNAR
Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
[TBL] [Abstract][Full Text] [Related]
10. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
[TBL] [Abstract][Full Text] [Related]
11. Application of the pseudo-plaque assay for detection and titration of Crimean-Congo hemorrhagic fever virus.
Berber E; Canakoglu N; Yoruk MD; Tonbak S; Aktas M; Ertek M; Bolat Y; Kalkan A; Ozdarendeli A
J Virol Methods; 2013 Jan; 187(1):26-31. PubMed ID: 22906394
[TBL] [Abstract][Full Text] [Related]
12. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever.
Fels JM; Maurer DP; Herbert AS; Wirchnianski AS; Vergnolle O; Cross RW; Abelson DM; Moyer CL; Mishra AK; Aguilan JT; Kuehne AI; Pauli NT; Bakken RR; Nyakatura EK; Hellert J; Quevedo G; Lobel L; Balinandi S; Lutwama JJ; Zeitlin L; Geisbert TW; Rey FA; Sidoli S; McLellan JS; Lai JR; Bornholdt ZA; Dye JM; Walker LM; Chandran K
Cell; 2021 Jun; 184(13):3486-3501.e21. PubMed ID: 34077751
[TBL] [Abstract][Full Text] [Related]
13. Crimean-Congo Hemorrhagic Fever Virus, Mongolia, 2013-2014.
Voorhees MA; Padilla SL; Jamsransuren D; Koehler JW; Delp KL; Adiyadorj D; Baasandagwa U; Jigjav B; Olschner SP; Minogue TD; Schoepp RJ
Emerg Infect Dis; 2018 Dec; 24(12):2202-2209. PubMed ID: 30457521
[TBL] [Abstract][Full Text] [Related]
14. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
[TBL] [Abstract][Full Text] [Related]
15. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model.
Kempster S; Hassall M; Graham V; Kennedy E; Findlay-Wilson S; Salguero FJ; Bagci B; Elaldi N; Oz M; Tasseten T; Charlton FW; Barr JN; Fontana J; Duru C; Ezeajughi E; Matejtschuk P; Arnold U; Adedeji Y; Mirazimi A; Hewson R; Dowall S; Almond N
Virus Res; 2024 Aug; 346():199409. PubMed ID: 38815869
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].
Uyar Y; Carhan A; Albayrak N; Altaş AB
Mikrobiyol Bul; 2010 Jan; 44(1):57-64. PubMed ID: 20455399
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Crimean-Congo hemorrhagic fever virus in ruminant species slaughtered in several endemic provinces in Turkey.
Ozan E; Ozkul A
Arch Virol; 2020 Aug; 165(8):1759-1767. PubMed ID: 32435856
[TBL] [Abstract][Full Text] [Related]
18. Investigation of an isolated case of human Crimean-Congo hemorrhagic fever in Central Uganda, 2015.
Balinandi S; Patel K; Ojwang J; Kyondo J; Mulei S; Tumusiime A; Lubwama B; Nyakarahuka L; Klena JD; Lutwama J; Strӧher U; Nichol ST; Shoemaker TR
Int J Infect Dis; 2018 Mar; 68():88-93. PubMed ID: 29382607
[TBL] [Abstract][Full Text] [Related]
19. Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.
Emmerich P; von Possel R; Deschermeier C; Ahmeti S; Berisha L; Halili B; Jakupi X; Sherifi K; Messing C; Borchardt-Lohölter V
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009280. PubMed ID: 33720942
[TBL] [Abstract][Full Text] [Related]
20. Hemorrhagic fever with renal syndrome and Crimean-Congo hemorrhagic fever as causes of acute undifferentiated febrile illness in Bulgaria.
Christova I; Younan R; Taseva E; Gladnishka T; Trifonova I; Ivanova V; Spik K; Schmaljohn C; Mohareb E
Vector Borne Zoonotic Dis; 2013 Mar; 13(3):188-92. PubMed ID: 23421884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
